2020
DOI: 10.1136/bmjopen-2020-040917
|View full text |Cite
|
Sign up to set email alerts
|

Impact of a Pharmacist-included Mobile Geriatrics team intervention on potentially inappropriate drug prescribing: protocol for a prospective feasibility study (PharMoG study)

Abstract: IntroductionResearch has shown that potentially inappropriate drug prescription (PIDP) is highly prevalent in older people. The presence of PIDPs is associated with adverse health outcomes. This study aims to evaluate the impact of a PHARmacist-included MObile Geriatrics (PharMoG) team intervention on PIDPs in older patients hospitalised in the medical, surgical and emergency departments of a university hospital.Methods and analysisThe PharMoG study is a prospective, interventional, single-centre feasibility s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 36 publications
0
1
0
Order By: Relevance
“…This combination of methods could also explain the benefit of the CP intervention. To our knowledge, no other interventional study has used both implicit and explicit methods to reduce the number of PIPs but some are ongoing [41]. In previous studies, CP interventions mainly consisted of the use of only one of these methods [23].…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…This combination of methods could also explain the benefit of the CP intervention. To our knowledge, no other interventional study has used both implicit and explicit methods to reduce the number of PIPs but some are ongoing [41]. In previous studies, CP interventions mainly consisted of the use of only one of these methods [23].…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…74.9% of the problems can be classified as misuse (according to expert opinions, contraindication, drug-drug interactions, side effects, pharmacodependance, drug monitoring, not first line), 23.2% as overuse (overdosage, redundancy, no indication HAS indicators), and 1.9% as underuse [ 49 ] “Table 2 ”.…”
Section: Resultsmentioning
confidence: 99%